MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-29-2026
Teva Pharmaceutical Industries Limited DIO Ratio 2011-2026 | TEVA
Annual DIO Ratio Teva Pharmaceutical Industries Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 136 | 151 | 175 | 176 | 181 | 180 | 173 | 164 | 155 | 180 | 174 | 173 | 192 | 208 | 208 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 208 | 136 | 175 |
Quarterly DIO Ratio Teva Pharmaceutical Industries Limited
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 147 | 143 | 148 | 163 | 165 | 168 | 178 | 186 | 180 | 174 | - | 91.4 | 91.9 | 186 | - | 186 | 196 | 191 | - | 189 | 191 | 176 | - | 178 | 177 | 182 | - | 169 | 162 | 160 | - | 151 | 157 | 160 | - | 153 | 166 | 179 | - | 185 | 186 | 182 | - | 193 | 190 | 199 | - | 199 | 210 | 215 | - | 207 | 207 | 189 | - | 199 | 197 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 215 | 91.4 | 176 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Happiness Biotech Group Limited
HAPP
|
1.91 K | - | 1.35 % | $ 17.8 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
150 | $ 35.0 | 1.6 % | $ 942 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.65 | 1.85 % | $ 439 M | Britain |
 |
Grifols, S.A.
GRFS
|
0.000171 | $ 8.11 | -0.98 % | $ 5.51 B |  Spain |
 |
Cyclacel Pharmaceuticals
CYCCP
|
185 | - | -4.36 % | $ 27 M | USA |
 |
Heron Therapeutics
HRTX
|
644 | $ 0.87 | 3.09 % | $ 145 M | USA |
 |
Anika Therapeutics
ANIK
|
159 | $ 15.02 | -0.79 % | $ 215 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Incyte Corporation
INCY
|
78.4 | $ 97.41 | 0.34 % | $ 19 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
259 | $ 75.78 | 0.96 % | $ 12.1 B | USA |
 |
Coherus BioSciences
CHRS
|
97.5 | $ 1.57 | 3.97 % | $ 184 M | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 21.01 | 2.64 % | $ 2.67 B | USA |